Status:
UNKNOWN
PhysioFlow to Detect Cardiotoxicity in Chemo
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Chemotherapy, Cancer, Cardiotoxicity, Physioflow
Eligibility:
All Genders
18+ years
Brief Summary
PULSE-ECCho will focus on trying to detect cardiotoxicity in cancer patients receiving chemotherapy early on in order to avoid irreversible damage. In addition to that, we will test if the PhysioFlow ...
Detailed Description
Our objective is to compare the PhysioFlow to the MUGA scan and see if the results are statistically the same using both techniques. This is what is known as a non-inferior study. The advantage of Phy...
Eligibility Criteria
Inclusion
- Age above 18 years old
- Histologically confirmed diagnosis of cancer
- ECOG 0 to 2
- Provide written consent after the investigational nature, study design, risks and benefits of the study have been explained
- Able to adhere to the study visit schedule and other protocol requirements
- Control Group
- Age above 18 years old
- No previous history of cancer
- ECOG 0 to 2
- Did not receive chemotherapeutic agents (even if outside the context of cancer)
- Provide written consent after the investigational nature, study design, risks and benefits of the study have been explained
- Able to adhere to the study visit schedule and other protocol requirements
Exclusion
- Age less than 18 years
- ECOG 3-4
- Suspected or proven severe aortic insufficiency
- Patient under cardiopulmonary bypass assistance (I.e.: Left ventricular assisting device)
- Congenital cardiac deformities ,such as septal defects
- Refuse to comply with the specified visit schedules and requirements
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02220569
Start Date
October 1 2014
End Date
July 1 2016
Last Update
September 23 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill university health center, Royal Victoria hospital
Montreal, Quebec, Canada, h3a 1a1
2
Royal Victoria Hospital
Montreal, Quebec, Canada, h4a 1v3